Journal of Clinical Pharmacy & Therapeutics

Augmentation strategies for treatment-resistant depression: a literature review
pp. 415-428(14)
Authors: Carvalho, A. F.; Cavalcante, J. L.; Castelo, M. S.; Lima, M. C. O.

Antimalarial drug quality in Africa
pp. 429-440(12)
Authors: Amin, A. A.; Kokwaro, G. O.

Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients
pp. 441-444(4)
Authors: Negro, S; Salama, A; Sánchez, Y; Azuara, M. L.; Barcia, E

RT-PCR-based cytochrome P450 expression profile of oral tissue samples
pp. 445-448(4)
Authors: Sarikaya, D.; Chiba, I.; Bilgen, C.; KamatakiI, T.; Topcu, Z.

Paracetamol (acetaminophen) pack size restrictions and poisoning severity: time trends in enquiries to a UK poisons centre
pp. 449-455(7)
Authors: Morgan, O.; Hawkins, L.; Edwards, N.; Dargan, P.

Possible case of potentiation of the antiplatelet effect of cilostazol by grapefruit juice
pp. 457-459(3)
Authors: Taniguchi, K.; Ohtani, H.; Ikemoto, T.; Miki, A.; Hori, S.; Sawada, Y.

Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol
pp. 461-467(7)
Authors: Kim, Jong-Hoon; Byun, Hee-Jung

A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting
pp. 469-476(8)
Authors: Finkers, F.; Maring, J. G.; Boersma, F.; Taxis, K.

Fat distribution and endothelial function in normal-overweight menopausal women
pp. 477-482(6)
Authors: Marchesi, S.; Vaudo, G.; Lupattelli, G.; Lombardini, R.; Roscini, A. R.; Brozzetti, M.; Siepi, D.; Mannarino, E.

Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study
pp. 483-487(5)
Authors: Heaton, P. C.; Fenwick, S. R.; Brewer, D. E.

Compounding of vitamin A, D₃, E and K₃ supplements for cystic fibrosis patients: formulation and stability study
pp. 489-496(8)
Authors: Huyghebaert, N.; De Beer, J.; Vervaet, C.; Remon, J. P.

Harm minimization strategies: opinions of health professionals in rural and remote Australia
pp. 497-504(8)
Authors: Peterson, G. M.; Northeast, S.; Jackson, S. L.; Fitzmaurice, K. D.

Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients
pp. 505-515(11)
Authors: Li, D.; Lu, W.; Zhu, J.-Y.; Gao, J.; Lou, Y.-Q.; Zhang, G.-L.

Effects of CYP2C19 genetic polymorphism on the pharmacokinetics and pharmacodynamics of omeprazole in Chinese people
pp. 517-524(8)
Authors: Hu, Xiang-peng; Xu, Jian-ming; Hu, Yong-mei; Mei, Qiao; Xu, Xin-hua

Minimizing antipsychotic medication obviated the need for enema against severe constipation leading to paralytic ileus: a case report
pp. 525-527(3)
Authors: Suzuki, T.; Uchida, H.; Watanabe, K.; Kashima, H.

Venlafaxine-lithium toxicity: suitability for use in the elderly
pp. 529-531(3)
Author: Gillman, Ken

BOOK REVIEW
pp. 533-533(1)
Authors: Martin, John; Kendall, Martin

ERRATUM
pp. 534-534(1)